Crucial Areas on AF Termination
Completed
- Conditions
- Atrial Fibrilation Termination Endpoint
- Registration Number
- NCT02099643
- Lead Sponsor
- Hospital St. Joseph, Marseille, France
- Brief Summary
Recent data has demonstrated that focal sources are determinant in human atrial fibrillation (AF) perpetuation.
The investigators sought to identify crucial areas for AF perpetuation during our routine electrogram (EGM)-based substrate ablation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 113
Inclusion Criteria
- Atrial Fibrilation
- Undergoing EGM-based substrate ablation
Exclusion Criteria
- Age < 18
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Atria fibrillation termination during procedure 240 min conversion to atrial tachycardia (AT) or sinus rhythm
- Secondary Outcome Measures
Name Time Method Crucial points 240 min Crucial points were defined by areas where ablation immediately extended the cycle length\> 20% of AF CL, or regularized Atrial Fibrilation (AF) into Atrial Tachycardia (AT) or converted AF (or AT) into Sinus Rythm
Trial Locations
- Locations (4)
Hopital Saint Joseph
🇫🇷Marseille, France
Institut Mutualiste Montsouris;
🇫🇷Paris, France
Hôpital Privé Jacques Cartier;
🇫🇷Massy, France
Morphology Unit Royal Brompton Hospital
🇬🇧London;, United Kingdom